Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors.
about
Environmental and Pharmacological Modulation of Amphetamine- Induced 50-kHz Ultrasonic Vocalizations in RatsAcute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis studyChronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortexα- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult ratsEffects of psychotropic agents on extinction of lever-press avoidance in a rat model of anxiety vulnerability.The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo.Structural and functional models of depression: from sub-types to substrates.Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss.Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors.Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus.Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems.
P2860
Q26786488-4DB977CD-25E6-42D9-B22B-409FEFC719E6Q28345792-945C0756-D3A3-4B72-B7D7-78FAFA7FB30CQ28345858-6AB165B9-2BC2-4652-B31F-D3DAC9376F2DQ30458757-7A6A9953-CA42-41C9-A9F9-EEEC2341B8D0Q34180554-6DB64EC8-52E8-4142-9E34-95327248720AQ35371943-C672E488-1B76-46EF-BF09-385BEE8EC095Q36018497-EC6BB9CB-1FA9-4D3F-94C9-801ED826BDD1Q36896730-6D9B8795-DD58-4031-A174-56EA8BCDC9D4Q37307278-500A68E2-881A-4C17-81DC-6175A25AC837Q37469310-B580887A-0044-43E0-942E-51AAD3F4C142Q38316708-EC73B7D8-828E-40F6-AFC8-CDC9D9276B1EQ42473400-75C74AF2-AE0F-42CD-82F5-8435DAC9779EQ44490449-B06CC427-734C-4530-B956-A7BA9F0FE20B
P2860
Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chronic treatment with desipra ...... synaptic alpha2-adrenoceptors.
@ast
Chronic treatment with desipra ...... synaptic alpha2-adrenoceptors.
@en
type
label
Chronic treatment with desipra ...... synaptic alpha2-adrenoceptors.
@ast
Chronic treatment with desipra ...... synaptic alpha2-adrenoceptors.
@en
prefLabel
Chronic treatment with desipra ...... synaptic alpha2-adrenoceptors.
@ast
Chronic treatment with desipra ...... synaptic alpha2-adrenoceptors.
@en
P2093
P356
P1476
Chronic treatment with desipra ...... synaptic alpha2-adrenoceptors.
@en
P2093
Sacchetti G
P2888
P356
10.1007/S002100000334
P577
2001-01-01T00:00:00Z
P6179
1038902114